HSBC Maintains Reduce on Eli Lilly, Raises Price Target to $940

Benzinga · 2d ago
HSBC analyst Rajesh Kumar maintains Eli Lilly (NYSE:LLY) with a Reduce and raises the price target from $850 to $940.